News & Topics Past News
2016.09.28
Approval in Japan of the Anti-cancer Drug TREAKISYM® Intravenous Infusion 25 mg
2016.09.27
Onconova Announces Results of End-of-Phase 2 Meeting with FDA regarding Plans for Pivotal Phase 3 Oral Rigosertib/Azacitidine Combination Trial for Higher-risk Myelodysplastic Syndromes
2016.09.15
Notice of the Setting of the Record Date in respect of the Convocation of the Extraordinary Shareholders' Meeting
2016.09.15
Notice concerning Partial Amendment to the Articles of Incorporation
2016.09.12
Analyst Report: Shared Research updates the report
2016.08.26
Approval of the Anti-cancer Drug TREAKISYM® for the Additional Indication of Chronic Lymphocytic Leukemia
2016.08.04
Analyst Report: Shared Research updates the report
2016.08.04
Summary of Financial Results For the Second Quarter of Fiscal Year Ending December 31, 2016[Japanese GAAP](Non-consolidated)
2016.08.04
Notice Concerning Non-operating Expenses
2016.07.19
Initiation of Patient Enrollment in Japan for the Global Randomized Phase 3 Trial of IV Rigosertib for Higher-risk Myelodysplastic Syndromes (MDS)
2016.07.11
Announcement on Achievement of a Sales Milestone for Bendamustine, an Anticancer Agent, in Taiwan, and Receipt of a Milestone Payment related thereto
2016.06.16
Corporate governance policies
2016.06.14
Onconova Announces Presentation of Clinical Data from Oral Rigosertib/Azacitidine Combination Study in Higher-Risk Myelodysplastic Syndromes at EHA Annual Meeting
2016.06.13
Analyst Report: Shared Research updates the report
2016.06.13
Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug "SyB P-1501"
2016.06.08
Notice concerning the Change of Major Shareholder
2016.06.07
Onconova Announces Poster Presentations for Oral Rigosertib/Azacitidine Combination and IV Rigosertib at 2016 ASCO Annual Meeting
2016.06.02
Onconova Announces Upcoming Rigosertib Clinical Trial Presentations for 2016 ASCO Annual Meeting
2016.05.30
Notice concerning the Change of Major Shareholder
2016.05.24
Notice concerning the Change of Major Shareholder
2016.05.20
Notice concerning Cancellation of the Extraordinary Shareholders' Meeting on July 15, 2016 and Cancellation of the Record Date therefor
2016.05.19
Notice concerning the Change of Major and Largest Shareholder among the Company's Major Stockholders